Global Microbiome Sequencing Services Market Size, Trends, By Technology (Sequencing By Synthesis, Sequencing By Ligation, Pyrosequencing, Sanger Sequencing, Other technologies), By Application (Shotgun Sequencing, Targeted Gene Sequencing, RNA Sequencing, Whole Genome Sequencing, Other Applications) and By End User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes), By Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa): Growth Opportunity Analysis and Industry Forecast, 2023-2030.
Global Microbiome Sequencing Services Market
The Global Microbiome Sequencing Services Market was valued at USD 250 billion in 2022 and is expected to expand to USD 666 billion by 2030, at a CAGR of 11.19% during the forecast period 2023-2030.
Microbiome sequencing services is a type of method of decoding the genetic material of all the microorganisms in a sample; viruses, bacteria, fungi, and protists. 2 major methods are used in microbiome sequencing: 1. Whole genome shotgun sequencing (WGS) and 2. Amplicon sequencing.
It is a type of technology that assists in evaluating microflora in human biota to know the function of microbes and their illnesses. Previous traditional microbiology methods have been utilized for examining the make-up and genotype of an individual for samples of urine, blood, and hair.
Market Drivers
The increasing the focus on human microbiome therapy across the globe acts as one of the major driving factors for the growth of the microbiome sequencing services market. The use of genomics, DNA research, technological advances in microbiome processing outcomes, metabolomics, and utilization of the human microbiome as a new validated target for drug development further accelerate the market growth.
Furthermore, the expansion of the biotechnology industry, the surge in the expenditure of healthcare infrastructure, and advancements in life sciences positively affect the microbiome sequencing services market in the forecast period of 2030.
Market Restraints
Various difficulties in proving the causal link between dysbiosis & disease and the lack of skilled technicians for NGS data analysis & detailed research are expected to restrain the global microbiome sequencing services market growth. The presence of stringent government regulations is projected to challenge the market in the forecast period of 2030.
Market Segmentation
The global microbiome sequencing services market is segmented into technology (sequencing by synthesis, sequencing by ligation, pyrosequencing, sanger sequencing, other technologies), application (shotgun sequencing, targeted gene sequencing, RNA sequencing, whole genome sequencing, other applications), and end-user (pharmaceutical and biotechnology companies, academic research institutes).
Regional Analysis
The global microbiome sequencing services market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North American region is expected to dominate the microbiome sequencing services market owing to the favorable reimbursement policies by governmental bodies within the region. The rising adoption of highly advanced technology & system in microbiome sequencing services is expected to boost the growth of the market in the North American region.
Also, the Asia-Pacific region is anticipated to witness significant growth during the forecast period of 2023 to 2030 because of developing healthcare infrastructure in the region.
Key Players
Various key players are discussed in the global microbiome sequencing services market report including; Baseclear B.V., Clinical-Microbiomics A/S, Molzym GmbH & Co. Kg, Zymo Research Corp., Rancho Biosciences, Microbiome Therapeutics, LLC., Microbiome Insights Inc., Openbiome, Resphera Biosciences, LLC., Ubiome, Inc., and Others.
Market Taxonomy
By Technology
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook